-
1
-
-
0021744364
-
A double blind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer
-
Al-Habbal M.J., Al-Habbal Z., and Huwez F.U. A double blind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer. Clin. Exp. Pharmacol. Physiol. 11 (1984) 541-544
-
(1984)
Clin. Exp. Pharmacol. Physiol.
, vol.11
, pp. 541-544
-
-
Al-Habbal, M.J.1
Al-Habbal, Z.2
Huwez, F.U.3
-
2
-
-
0022542225
-
Evaluation of mastic a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity
-
Al Said M., Ageel A.M., Parmar M.S., and Tariq M. Evaluation of mastic a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity. J. Ethnopharmacol. 15 (1986) 271-278
-
(1986)
J. Ethnopharmacol.
, vol.15
, pp. 271-278
-
-
Al Said, M.1
Ageel, A.M.2
Parmar, M.S.3
Tariq, M.4
-
3
-
-
26844453333
-
GC-MS analysis of penta- and tetracyclic-triterpenes from resin of Pistacia species. Part II. Pistacia terebiuthus var
-
Assimopoulou A.N., and Papageorgiou V.P. GC-MS analysis of penta- and tetracyclic-triterpenes from resin of Pistacia species. Part II. Pistacia terebiuthus var. Chia. Biomed. Chromatogr. 19 8 (2005) 586-605
-
(2005)
Chia. Biomed. Chromatogr.
, vol.19
, Issue.8
, pp. 586-605
-
-
Assimopoulou, A.N.1
Papageorgiou, V.P.2
-
4
-
-
34548337135
-
Characterization of the volatile constituents in the essential oil of Pistacia lentiscus L. from different origins and its antifungal and antioxidant activity
-
Barra A., Coroneo V., Dessi S., Cabros P., and Angioni A. Characterization of the volatile constituents in the essential oil of Pistacia lentiscus L. from different origins and its antifungal and antioxidant activity. J. Agric. Food Chem. 55 17 (2007) 7093-7098
-
(2007)
J. Agric. Food Chem.
, vol.55
, Issue.17
, pp. 7093-7098
-
-
Barra, A.1
Coroneo, V.2
Dessi, S.3
Cabros, P.4
Angioni, A.5
-
6
-
-
33744527899
-
Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic and experimental evidence
-
Eslick J.D. Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic and experimental evidence. World J. Gastroenterol. 12 (2006) 2991-2999
-
(2006)
World J. Gastroenterol.
, vol.12
, pp. 2991-2999
-
-
Eslick, J.D.1
-
7
-
-
0018573876
-
Moronic acid a simple triterpenoid keto- acid with antimicrobial activity isolated from Ozorooa mucronata
-
Hostettmann-Kaldas M., and Nakanishi M. Moronic acid a simple triterpenoid keto- acid with antimicrobial activity isolated from Ozorooa mucronata. Planta Med. 37 (1979) 358-360
-
(1979)
Planta Med.
, vol.37
, pp. 358-360
-
-
Hostettmann-Kaldas, M.1
Nakanishi, M.2
-
9
-
-
33846984273
-
Chios mastic treatment of patients with active Crohn's disease
-
Kaliora, A.C., Stathopoulou, M.G., Triantafillidis, J.K., Dedoussis, G.V., Andikopoulos, N.K., 2007. Chios mastic treatment of patients with active Crohn's disease. World J. Gastroenterol. 13, 748-753
-
(2007)
World J. Gastroenterol
, vol.13
, pp. 748-753
-
-
Kaliora, A.C.1
Stathopoulou, M.G.2
Triantafillidis, J.K.3
Dedoussis, G.V.4
Andikopoulos, N.K.5
-
10
-
-
33846570019
-
Evaluation of the toxicity of mastic gum with 13 weeks dietary administration to F344 rats
-
Kang J.S., Wanibuchi H., Salim E.I., Kinoshita A., and Fukushima S. Evaluation of the toxicity of mastic gum with 13 weeks dietary administration to F344 rats. Food Chem. Toxicol. 45 (2007) 494-501
-
(2007)
Food Chem. Toxicol.
, vol.45
, pp. 494-501
-
-
Kang, J.S.1
Wanibuchi, H.2
Salim, E.I.3
Kinoshita, A.4
Fukushima, S.5
-
11
-
-
33947193628
-
Helicobacter pylori and benign upper digestive diseases
-
Lai L.H., and Sung J.J. Helicobacter pylori and benign upper digestive diseases. Best Pract. Res. Clin. Gastroenterol. 21 (2007) 261-279
-
(2007)
Best Pract. Res. Clin. Gastroenterol.
, vol.21
, pp. 261-279
-
-
Lai, L.H.1
Sung, J.J.2
-
12
-
-
0037323737
-
Monotherapy with mastic gum does not eradicate Helicobacter pylori infection from mice
-
Loughlin M.F., Ala'Aldeen D.A., and Jenks P.J. Monotherapy with mastic gum does not eradicate Helicobacter pylori infection from mice. J. Antimicrob. Chemother. 51 (2003) 367-371
-
(2003)
J. Antimicrob. Chemother.
, vol.51
, pp. 367-371
-
-
Loughlin, M.F.1
Ala'Aldeen, D.A.2
Jenks, P.J.3
-
13
-
-
33846315613
-
Epidemiology of Helicobacter pylori infection
-
Magalhaes-Queiroz D.M., and Luzza F. Epidemiology of Helicobacter pylori infection. Helicobacter 11 Suppl.1 (2006) 1-5
-
(2006)
Helicobacter
, vol.11
, Issue.SUPPL.1
, pp. 1-5
-
-
Magalhaes-Queiroz, D.M.1
Luzza, F.2
-
14
-
-
34247844165
-
Current concepts in the management of Helicobacter pylori infection: the Masstricht III consensus report
-
Malfetrheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., et al. Current concepts in the management of Helicobacter pylori infection: the Masstricht III consensus report. Gut 56 (2007) 772-781
-
(2007)
Gut
, vol.56
, pp. 772-781
-
-
Malfetrheiner, P.1
Megraud, F.2
O'Morain, C.3
Bazzoli, F.4
El-Omar, E.5
Graham, D.6
-
15
-
-
0035696437
-
Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori
-
Marone P., Bono L., Leone F., Bona S., Carretto E., and Perversi L. Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori. J. Chemother. 13 (2001) 611-614
-
(2001)
J. Chemother.
, vol.13
, pp. 611-614
-
-
Marone, P.1
Bono, L.2
Leone, F.3
Bona, S.4
Carretto, E.5
Perversi, L.6
-
16
-
-
33846649032
-
In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori
-
Paraschos S., Magiatis P., Mitakou S., Petraki K., Kalliaropoulos A., Maragkoudakis P., et al. In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori. Antimicrob. Agents Chemother. 51 (2007) 551-559
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, pp. 551-559
-
-
Paraschos, S.1
Magiatis, P.2
Mitakou, S.3
Petraki, K.4
Kalliaropoulos, A.5
Maragkoudakis, P.6
|